 | • レポートコード：MRC2-11QY01779 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインターロイキン12受容体のグローバル市場について調査・分析したレポートです。種類別（エドデキンアルファSR、M-9241、LY-3232094、NMIL-121、その他）市場規模、用途別（入院患者、外来患者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インターロイキン12受容体の競争状況、市場シェア ・世界のインターロイキン12受容体市場：種類別市場規模 2015年-2020年（エドデキンアルファSR、M-9241、LY-3232094、NMIL-121、その他） ・世界のインターロイキン12受容体市場：種類別市場規模予測 2021年-2026年（エドデキンアルファSR、M-9241、LY-3232094、NMIL-121、その他） ・世界のインターロイキン12受容体市場：用途別市場規模 2015年-2020年（入院患者、外来患者） ・世界のインターロイキン12受容体市場：用途別市場規模予測 2021年-2026年（入院患者、外来患者） ・北米のインターロイキン12受容体市場分析：米国、カナダ ・ヨーロッパのインターロイキン12受容体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインターロイキン12受容体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインターロイキン12受容体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインターロイキン12受容体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly and Company、Mallinckrodt Plc、Merck KGaA、Neumedicines Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Interleukin 12 Receptor Market
The global Interleukin 12 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Interleukin 12 Receptor Scope and Market Size
Interleukin 12 Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interleukin 12 Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Interleukin 12 Receptor market is segmented into
Edodekin Alfa SR
M-9241
LY-3232094
NMIL-121
Others
Segment by Application, the Interleukin 12 Receptor market is segmented into
In-Patient
Out-Patient
Regional and Country-level Analysis
The Interleukin 12 Receptor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Interleukin 12 Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Interleukin 12 Receptor Market Share Analysis
Interleukin 12 Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Interleukin 12 Receptor business, the date to enter into the Interleukin 12 Receptor market, Interleukin 12 Receptor product introduction, recent developments, etc.
The major vendors covered:
Eli Lilly and Company
Mallinckrodt Plc
Merck KGaA
Neumedicines Inc
…
1 Study Coverage
1.1 Interleukin 12 Receptor Product Introduction
1.2 Market Segments
1.3 Key Interleukin 12 Receptor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Interleukin 12 Receptor Market Size Growth Rate by Type
1.4.2 Edodekin Alfa SR
1.4.3 M-9241
1.4.4 LY-3232094
1.4.5 NMIL-121
1.4.6 Others
1.5 Market by Application
1.5.1 Global Interleukin 12 Receptor Market Size Growth Rate by Application
1.5.2 In-Patient
1.5.3 Out-Patient
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Interleukin 12 Receptor Market Size, Estimates and Forecasts
2.1.1 Global Interleukin 12 Receptor Revenue 2015-2026
2.1.2 Global Interleukin 12 Receptor Sales 2015-2026
2.2 Global Interleukin 12 Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Interleukin 12 Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Interleukin 12 Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Interleukin 12 Receptor Competitor Landscape by Players
3.1 Interleukin 12 Receptor Sales by Manufacturers
3.1.1 Interleukin 12 Receptor Sales by Manufacturers (2015-2020)
3.1.2 Interleukin 12 Receptor Sales Market Share by Manufacturers (2015-2020)
3.2 Interleukin 12 Receptor Revenue by Manufacturers
3.2.1 Interleukin 12 Receptor Revenue by Manufacturers (2015-2020)
3.2.2 Interleukin 12 Receptor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Interleukin 12 Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Interleukin 12 Receptor Revenue in 2019
3.2.5 Global Interleukin 12 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Interleukin 12 Receptor Price by Manufacturers
3.4 Interleukin 12 Receptor Manufacturing Base Distribution, Product Types
3.4.1 Interleukin 12 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Interleukin 12 Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Interleukin 12 Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Interleukin 12 Receptor Market Size by Type (2015-2020)
4.1.1 Global Interleukin 12 Receptor Sales by Type (2015-2020)
4.1.2 Global Interleukin 12 Receptor Revenue by Type (2015-2020)
4.1.3 Interleukin 12 Receptor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Interleukin 12 Receptor Market Size Forecast by Type (2021-2026)
4.2.1 Global Interleukin 12 Receptor Sales Forecast by Type (2021-2026)
4.2.2 Global Interleukin 12 Receptor Revenue Forecast by Type (2021-2026)
4.2.3 Interleukin 12 Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Interleukin 12 Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Interleukin 12 Receptor Market Size by Application (2015-2020)
5.1.1 Global Interleukin 12 Receptor Sales by Application (2015-2020)
5.1.2 Global Interleukin 12 Receptor Revenue by Application (2015-2020)
5.1.3 Interleukin 12 Receptor Price by Application (2015-2020)
5.2 Interleukin 12 Receptor Market Size Forecast by Application (2021-2026)
5.2.1 Global Interleukin 12 Receptor Sales Forecast by Application (2021-2026)
5.2.2 Global Interleukin 12 Receptor Revenue Forecast by Application (2021-2026)
5.2.3 Global Interleukin 12 Receptor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Interleukin 12 Receptor by Country
6.1.1 North America Interleukin 12 Receptor Sales by Country
6.1.2 North America Interleukin 12 Receptor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Interleukin 12 Receptor Market Facts & Figures by Type
6.3 North America Interleukin 12 Receptor Market Facts & Figures by Application
7 Europe
7.1 Europe Interleukin 12 Receptor by Country
7.1.1 Europe Interleukin 12 Receptor Sales by Country
7.1.2 Europe Interleukin 12 Receptor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Interleukin 12 Receptor Market Facts & Figures by Type
7.3 Europe Interleukin 12 Receptor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Interleukin 12 Receptor by Region
8.1.1 Asia Pacific Interleukin 12 Receptor Sales by Region
8.1.2 Asia Pacific Interleukin 12 Receptor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Interleukin 12 Receptor Market Facts & Figures by Type
8.3 Asia Pacific Interleukin 12 Receptor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Interleukin 12 Receptor by Country
9.1.1 Latin America Interleukin 12 Receptor Sales by Country
9.1.2 Latin America Interleukin 12 Receptor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Interleukin 12 Receptor Market Facts & Figures by Type
9.3 Central & South America Interleukin 12 Receptor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Interleukin 12 Receptor by Country
10.1.1 Middle East and Africa Interleukin 12 Receptor Sales by Country
10.1.2 Middle East and Africa Interleukin 12 Receptor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Interleukin 12 Receptor Market Facts & Figures by Type
10.3 Middle East and Africa Interleukin 12 Receptor Market Facts & Figures by Application
11 Company Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Corporation Information
11.1.2 Eli Lilly and Company Description and Business Overview
11.1.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly and Company Interleukin 12 Receptor Products Offered
11.1.5 Eli Lilly and Company Related Developments
11.2 Mallinckrodt Plc
11.2.1 Mallinckrodt Plc Corporation Information
11.2.2 Mallinckrodt Plc Description and Business Overview
11.2.3 Mallinckrodt Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Mallinckrodt Plc Interleukin 12 Receptor Products Offered
11.2.5 Mallinckrodt Plc Related Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Corporation Information
11.3.2 Merck KGaA Description and Business Overview
11.3.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck KGaA Interleukin 12 Receptor Products Offered
11.3.5 Merck KGaA Related Developments
11.4 Neumedicines Inc
11.4.1 Neumedicines Inc Corporation Information
11.4.2 Neumedicines Inc Description and Business Overview
11.4.3 Neumedicines Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Neumedicines Inc Interleukin 12 Receptor Products Offered
11.4.5 Neumedicines Inc Related Developments
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Corporation Information
11.1.2 Eli Lilly and Company Description and Business Overview
11.1.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly and Company Interleukin 12 Receptor Products Offered
11.1.5 Eli Lilly and Company Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Interleukin 12 Receptor Market Estimates and Projections by Region
12.1.1 Global Interleukin 12 Receptor Sales Forecast by Regions 2021-2026
12.1.2 Global Interleukin 12 Receptor Revenue Forecast by Regions 2021-2026
12.2 North America Interleukin 12 Receptor Market Size Forecast (2021-2026)
12.2.1 North America: Interleukin 12 Receptor Sales Forecast (2021-2026)
12.2.2 North America: Interleukin 12 Receptor Revenue Forecast (2021-2026)
12.2.3 North America: Interleukin 12 Receptor Market Size Forecast by Country (2021-2026)
12.3 Europe Interleukin 12 Receptor Market Size Forecast (2021-2026)
12.3.1 Europe: Interleukin 12 Receptor Sales Forecast (2021-2026)
12.3.2 Europe: Interleukin 12 Receptor Revenue Forecast (2021-2026)
12.3.3 Europe: Interleukin 12 Receptor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Interleukin 12 Receptor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Interleukin 12 Receptor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Interleukin 12 Receptor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Interleukin 12 Receptor Market Size Forecast by Region (2021-2026)
12.5 Latin America Interleukin 12 Receptor Market Size Forecast (2021-2026)
12.5.1 Latin America: Interleukin 12 Receptor Sales Forecast (2021-2026)
12.5.2 Latin America: Interleukin 12 Receptor Revenue Forecast (2021-2026)
12.5.3 Latin America: Interleukin 12 Receptor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Interleukin 12 Receptor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Interleukin 12 Receptor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Interleukin 12 Receptor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Interleukin 12 Receptor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Interleukin 12 Receptor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Interleukin 12 Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Interleukin 12 Receptor Market Segments
Table 2. Ranking of Global Top Interleukin 12 Receptor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Interleukin 12 Receptor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Edodekin Alfa SR
Table 5. Major Manufacturers of M-9241
Table 6. Major Manufacturers of LY-3232094
Table 7. Major Manufacturers of NMIL-121
Table 8. Major Manufacturers of Others
Table 9. Global Interleukin 12 Receptor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Interleukin 12 Receptor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Interleukin 12 Receptor Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Interleukin 12 Receptor Sales Market Share by Regions (2015-2020)
Table 13. Global Interleukin 12 Receptor Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Interleukin 12 Receptor Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Interleukin 12 Receptor Sales Share by Manufacturers (2015-2020)
Table 16. Global Interleukin 12 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Interleukin 12 Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interleukin 12 Receptor as of 2019)
Table 18. Interleukin 12 Receptor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Interleukin 12 Receptor Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Interleukin 12 Receptor Price (2015-2020) (USD/Pcs)
Table 21. Interleukin 12 Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Interleukin 12 Receptor Product Type
Table 23. Date of International Manufacturers Enter into Interleukin 12 Receptor Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Interleukin 12 Receptor Sales by Type (2015-2020) (K Pcs)
Table 26. Global Interleukin 12 Receptor Sales Share by Type (2015-2020)
Table 27. Global Interleukin 12 Receptor Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Interleukin 12 Receptor Revenue Share by Type (2015-2020)
Table 29. Interleukin 12 Receptor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Interleukin 12 Receptor Sales by Application (2015-2020) (K Pcs)
Table 31. Global Interleukin 12 Receptor Sales Share by Application (2015-2020)
Table 32. North America Interleukin 12 Receptor Sales by Country (2015-2020) (K Pcs)
Table 33. North America Interleukin 12 Receptor Sales Market Share by Country (2015-2020)
Table 34. North America Interleukin 12 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Interleukin 12 Receptor Revenue Market Share by Country (2015-2020)
Table 36. North America Interleukin 12 Receptor Sales by Type (2015-2020) (K Pcs)
Table 37. North America Interleukin 12 Receptor Sales Market Share by Type (2015-2020)
Table 38. North America Interleukin 12 Receptor Sales by Application (2015-2020) (K Pcs)
Table 39. North America Interleukin 12 Receptor Sales Market Share by Application (2015-2020)
Table 40. Europe Interleukin 12 Receptor Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Interleukin 12 Receptor Sales Market Share by Country (2015-2020)
Table 42. Europe Interleukin 12 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Interleukin 12 Receptor Revenue Market Share by Country (2015-2020)
Table 44. Europe Interleukin 12 Receptor Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Interleukin 12 Receptor Sales Market Share by Type (2015-2020)
Table 46. Europe Interleukin 12 Receptor Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Interleukin 12 Receptor Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Interleukin 12 Receptor Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Interleukin 12 Receptor Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Interleukin 12 Receptor Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Interleukin 12 Receptor Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Interleukin 12 Receptor Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Interleukin 12 Receptor Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Interleukin 12 Receptor Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Interleukin 12 Receptor Sales Market Share by Application (2015-2020)
Table 56. Latin America Interleukin 12 Receptor Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Interleukin 12 Receptor Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Interleukin 12 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Interleukin 12 Receptor Revenue Market Share by Country (2015-2020)
Table 60. Latin America Interleukin 12 Receptor Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Interleukin 12 Receptor Sales Market Share by Type (2015-2020)
Table 62. Latin America Interleukin 12 Receptor Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Interleukin 12 Receptor Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Interleukin 12 Receptor Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Interleukin 12 Receptor Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Interleukin 12 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Interleukin 12 Receptor Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Interleukin 12 Receptor Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Interleukin 12 Receptor Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Interleukin 12 Receptor Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Interleukin 12 Receptor Sales Market Share by Application (2015-2020)
Table 72. Eli Lilly and Company Corporation Information
Table 73. Eli Lilly and Company Description and Major Businesses
Table 74. Eli Lilly and Company Interleukin 12 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Eli Lilly and Company Product
Table 76. Eli Lilly and Company Recent Development
Table 77. Mallinckrodt Plc Corporation Information
Table 78. Mallinckrodt Plc Description and Major Businesses
Table 79. Mallinckrodt Plc Interleukin 12 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Mallinckrodt Plc Product
Table 81. Mallinckrodt Plc Recent Development
Table 82. Merck KGaA Corporation Information
Table 83. Merck KGaA Description and Major Businesses
Table 84. Merck KGaA Interleukin 12 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Merck KGaA Product
Table 86. Merck KGaA Recent Development
Table 87. Neumedicines Inc Corporation Information
Table 88. Neumedicines Inc Description and Major Businesses
Table 89. Neumedicines Inc Interleukin 12 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Neumedicines Inc Product
Table 91. Neumedicines Inc Recent Development
Table 92. Global Interleukin 12 Receptor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 93. Global Interleukin 12 Receptor Sales Market Share Forecast by Regions (2021-2026)
Table 94. Global Interleukin 12 Receptor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 95. Global Interleukin 12 Receptor Revenue Market Share Forecast by Regions (2021-2026)
Table 96. North America: Interleukin 12 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. North America: Interleukin 12 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Europe: Interleukin 12 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Europe: Interleukin 12 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Asia Pacific: Interleukin 12 Receptor Sales Forecast by Region (2021-2026) (K Pcs)
Table 101. Asia Pacific: Interleukin 12 Receptor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 102. Latin America: Interleukin 12 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Latin America: Interleukin 12 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Middle East and Africa: Interleukin 12 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Middle East and Africa: Interleukin 12 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 107. Key Challenges
Table 108. Market Risks
Table 109. Main Points Interviewed from Key Interleukin 12 Receptor Players
Table 110. Interleukin 12 Receptor Customers List
Table 111. Interleukin 12 Receptor Distributors List
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Interleukin 12 Receptor Product Picture
Figure 2. Global Interleukin 12 Receptor Sales Market Share by Type in 2020 & 2026
Figure 3. Edodekin Alfa SR Product Picture
Figure 4. M-9241 Product Picture
Figure 5. LY-3232094 Product Picture
Figure 6. NMIL-121 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Interleukin 12 Receptor Sales Market Share by Application in 2020 & 2026
Figure 9. In-Patient
Figure 10. Out-Patient
Figure 11. Interleukin 12 Receptor Report Years Considered
Figure 12. Global Interleukin 12 Receptor Market Size 2015-2026 (US$ Million)
Figure 13. Global Interleukin 12 Receptor Sales 2015-2026 (K Pcs)
Figure 14. Global Interleukin 12 Receptor Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Interleukin 12 Receptor Sales Market Share by Region (2015-2020)
Figure 16. Global Interleukin 12 Receptor Sales Market Share by Region in 2019
Figure 17. Global Interleukin 12 Receptor Revenue Market Share by Region (2015-2020)
Figure 18. Global Interleukin 12 Receptor Revenue Market Share by Region in 2019
Figure 19. Global Interleukin 12 Receptor Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Interleukin 12 Receptor Revenue in 2019
Figure 21. Interleukin 12 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Interleukin 12 Receptor Sales Market Share by Type (2015-2020)
Figure 23. Global Interleukin 12 Receptor Sales Market Share by Type in 2019
Figure 24. Global Interleukin 12 Receptor Revenue Market Share by Type (2015-2020)
Figure 25. Global Interleukin 12 Receptor Revenue Market Share by Type in 2019
Figure 26. Global Interleukin 12 Receptor Market Share by Price Range (2015-2020)
Figure 27. Global Interleukin 12 Receptor Sales Market Share by Application (2015-2020)
Figure 28. Global Interleukin 12 Receptor Sales Market Share by Application in 2019
Figure 29. Global Interleukin 12 Receptor Revenue Market Share by Application (2015-2020)
Figure 30. Global Interleukin 12 Receptor Revenue Market Share by Application in 2019
Figure 31. North America Interleukin 12 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Interleukin 12 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Interleukin 12 Receptor Sales Market Share by Country in 2019
Figure 34. North America Interleukin 12 Receptor Revenue Market Share by Country in 2019
Figure 35. U.S. Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Interleukin 12 Receptor Market Share by Type in 2019
Figure 40. North America Interleukin 12 Receptor Market Share by Application in 2019
Figure 41. Europe Interleukin 12 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Interleukin 12 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Interleukin 12 Receptor Sales Market Share by Country in 2019
Figure 44. Europe Interleukin 12 Receptor Revenue Market Share by Country in 2019
Figure 45. Germany Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Interleukin 12 Receptor Market Share by Type in 2019
Figure 56. Europe Interleukin 12 Receptor Market Share by Application in 2019
Figure 57. Asia Pacific Interleukin 12 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Interleukin 12 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Interleukin 12 Receptor Sales Market Share by Region in 2019
Figure 60. Asia Pacific Interleukin 12 Receptor Revenue Market Share by Region in 2019
Figure 61. China Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Interleukin 12 Receptor Market Share by Type in 2019
Figure 84. Asia Pacific Interleukin 12 Receptor Market Share by Application in 2019
Figure 85. Latin America Interleukin 12 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Interleukin 12 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Interleukin 12 Receptor Sales Market Share by Country in 2019
Figure 88. Latin America Interleukin 12 Receptor Revenue Market Share by Country in 2019
Figure 89. Mexico Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Interleukin 12 Receptor Market Share by Type in 2019
Figure 96. Latin America Interleukin 12 Receptor Market Share by Application in 2019
Figure 97. Middle East and Africa Interleukin 12 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Interleukin 12 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Interleukin 12 Receptor Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Interleukin 12 Receptor Revenue Market Share by Country in 2019
Figure 101. Turkey Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Interleukin 12 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Interleukin 12 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Interleukin 12 Receptor Market Share by Type in 2019
Figure 108. Middle East and Africa Interleukin 12 Receptor Market Share by Application in 2019
Figure 109. North America Interleukin 12 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Interleukin 12 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Interleukin 12 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Interleukin 12 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Interleukin 12 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Interleukin 12 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Interleukin 12 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Interleukin 12 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Interleukin 12 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Interleukin 12 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
インターロイキン7受容体サブユニットアルファの世界市場（～2026年） Market Analysis and Insights: Global Interleukin 7 Receptor Subunit Alpha Market The global Interleukin 7 Receptor Subunit Alpha market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 7 Receptor Subunit Alpha Scop…- インターロイキン1受容体関連キナーゼ4の世界市場（～2026年） Market Analysis and Insights: Global Interleukin 1 Receptor Associated Kinase 4 Market The global Interleukin 1 Receptor Associated Kinase 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 1 Receptor Associ…
- インターロイキン1アルファの世界市場（～2026年） Market Analysis and Insights: Global Interleukin 1 Alpha Market The global Interleukin 1 Alpha market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 1 Alpha Scope and Market Size Interleukin 1 Alpha market is seg…
- インターロイキン阻害剤の世界市場（～2026年） Interleukin (IL) are group of cytokines that are synthesized by lymphocytes, monocytes, macrophages, and other cells. They regulate cell growth, cell differentiation, and cell motility. Fifteen different types of interleukin are present in body. Interleukin inhibitors are immunosuppressive agents th…
- インターロイキン1（IL1）の世界市場（～2026年） Market Analysis and Insights: Global Interleukin 1 (IL1) Market The global Interleukin 1 (IL1) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 1 (IL1) Scope and Market Size Interleukin 1 (IL1) market is seg…